Is BIOX a good stock to buy right now?

Based on our 6-factor quantitative model, Bioceres Crop Solutions Corp. (BIOX) receives a "Avoid" rating with a composite score of 29.3/100. It is ranked #4,022 out of 4,446 stocks. Key factor scores: Quality 34/100, Value 35/100, Momentum 6/100. The timing signal is "Bearish". This is quantitative analysis only — not investment advice.

What is the stock rating for BIOX?

Bioceres Crop Solutions Corp. (BIOX) has a "Avoid" rating and 1-star score. The composite score of 29.3 ranks it #4,022 among 4,446 U.S. stocks. Ratings are updated weekly using academically-proven factor models.

What sector is BIOX in?

Bioceres Crop Solutions Corp. operates in the Materials sector (Chemicals industry) with a market cap of $30 million. It is classified as a micro-cap stock.

Does BIOX pay a dividend?

BIOX does not currently pay a regular dividend. The company may be reinvesting profits for growth.

What is BIOX's P/E ratio?

P/E ratio data is not currently available for BIOX, which may indicate the company is not yet profitable.

How profitable is BIOX?

BIOX's quality factor score is 34/100. Gross margin: 30.0%. ROE: -88.7% vs sector average 3.3%. Margins are moderate to low, reflecting competitive market dynamics.

How is BIOX valued compared to peers?

BIOX's value factor score is 35/100 (higher = cheaper). Key multiples: . Trading at a premium relative to peers.

What is BIOX's debt level?

BIOX's debt-to-equity ratio is 104%. Sector average: 41%. Moderate leverage is normal for established companies.

BIOX has a beta of 1.30, meaning it amplifies market moves. Stability score: 20/100.

Does BIOX have high short interest?

BIOX's short interest factor score is 51/100 (higher = less short selling). Moderate short interest.

BIOX Stock Analysis: Top Micro-Cap Avoid (Score 29.3/100) | Blank Capital Research

Data Series	1D	5D	1M	YTD	1Y	3Y	5Y	10Y
BIOX	+4.97%	+1.98%	+4.93%	-57.94%	-86.53%	-	-	-
Industry Proxy XLB	+0.56%	+3.07%	+4.17%	+14.58%	-33.54%	-	-	-
U.S. Market SPY	-0.07%	+3.60%	+0.34%	-0.36%	+29.52%	-	-	-
Alpha vs Market	+5.04%	-1.62%	+4.60%	-57.58%	-116.05%	-	-	-
Alpha vs Sector	+4.41%	-1.09%	+0.76%	-72.51%	-52.99%	-	-	-

Metric	BIOX	Benchmark
P/E Ratio	-0.1x	-101%
EV/EBITDA	—	—
Price / Book	0.1x

Stock Entity	Score▼	Quality	Value	Momentum	P/E Ratio	ROE	Gross Margin	Net Margin	Rev Growth	D/E Ratio	Market Cap	Compare
CF CF Industries Holdings, Inc.	57	50	72	66	12.5x	21.1%	36.2%	24.9%	5.5%	41.0x	$19.7B	VS
NTR Nutrien Ltd.	57	37	70	64	53.5x	11.5%	29.0%	2.7%	-	52.0x	$35.9B	VS
UAN CVR PARTNERS, LP	56	50	71	67	12.2x	42.4%	28.5%	17.8%	23.1%	265.0x	$1.3B	VS
LXU LSB INDUSTRIES, INC.	54	50	54	73	39.7x	-3.3%	8.6%	-4.5%	11.0%	85.0x	$1.1B	VS
AA Alcoa Corp	54	50	61	71	19.0x	16.6%	10.0%	8.0%	3.1%	40.0x	$19.0B	VS
MEOH METHANEX CORP	53	34	76	72	23.8x	47.8%	19.1%	6.7%	-	149.0x	$4.6B	VS
NGVT Ingevity Corp	53	50	68	66	53.4x	-638.7%	38.1%	-12.1%	-14.7%	5,459.0x	$2.5B	VS
SEE SEALED AIR CORP/DE	52	50	67	59	11.2x	44.7%	30.2%	10.4%	0.5%	318.0x	$6.2B	VS
ACU ACME UNITED CORP	51	50	71	51	15.9x	9.0%	39.4%	5.2%	-11.5%	45.0x	$171M	VS
APD Air Products & Chemicals, Inc.	51	50	49	50	176.7x	2.4%	31.6%	2.2%	3.9%	114.0x	$64.4B	VS
BIOX Bioceres Crop Solutions Corp.	29	34	35	6	-	-88.7%	30.0%	-17.7%	-	104.0x	$30M

Key Ratio	TTM	2025	2024	2023	2022	2021	2020	2019	2018
Gross Margin %	0.3%	0.3%	0.3%	0.4%	0.3%	0.3%	0.5%	0.5%	0.4%
Operating Margin %	-0.1%	-0.1%	0.0%	0.1%	0.0%	0.1%	0.2%	0.2%	0.1%
EBITDA Margin %	-0.0%	-0.0%	0.1%	0.1%	0.1%	0.1%	0.1%	0.1%	0.0%
Net Margin %	-0.2%	-0.2%	0.0%	0.0%	-0.0%	-0.0%	0.0%	-0.1%	-0.1%
FCF Margin %	4.9%	4.9%	6.7%	-51.9%	-18.8%	-80.5%	4.5%	57.7%	-
ROE %	-0.9%	-0.2%	0.0%	0.1%	-0.3%	-0.1%	0.1%	-0.3%	-0.3%
ROA %	-0.3%	-0.1%	0.0%	0.0%	-0.0%	-0.0%	0.0%	-0.1%	-0.1%
ROIC %	-4.9%	-4.9%	2.2%	4.4%	6.3%	5.1%	57.7%	56.0%	9.1%

Line Item	TTM	2025	2024	2023	2022	2021	2020	2019	2018
	$332M	$332M	$462M	$415M	$328M	$207M	$171M	$161M	$133M
	$100M	$100M	$157M	$156M	$102M	$67M	$77M	$74M	$56M
Gross Margin	30.0%	30.0%	34.0%	37.5%	31.1%	32.3%	45.1%	45.9%	42.3%
	—	$15M	$17M	$15M	$7M	$6M	$4M	$4M	$4M
Depreciation	—	$17M	$21M	$16M	$8M	$5M	$5M	$5M	$4M
	-$32M	-$32M	$15M	$29M	$14M	$13M	$34M	$31M	$16M
EBIT	-$32M	-$32M	$15M	$29M	$14M	$13M	$34M	$31M	$16M
EBITDA	-$14M	-$14M	$40M	$45M	$32M	$23M	$13M	$13M	$758K
Operating Margin	-9.6%	-9.6%	3.2%	6.6%	4.4%	6.4%	20.0%	19.4%	11.8%
EBITDA Margin	-4.2%	-4.2%	8.7%	10.8%	9.9%	10.9%	7.8%	7.8%	0.6%
	—	$26M	$8M	$11M	$8M	$7M	—	—	—
	—	$1M	$4M	-$1M	$18M	$14M	$2M	$7M	-$11M
	-$59M	-$59M	$7M	$20M	-$4M	-$4M	$4M	-$16M	-$14M
Net Margin	-17.7%	-17.7%	1.6%	4.9%	-1.2%	-1.8%	2.5%	-10.2%	-10.7%

Bioceres Crop Solutions Corp. (BIOX) Stock Analysis — April 2026 Rating, Price, and Forecast

Last updated: April 2026

Company Overview — What Does Bioceres Crop Solutions Corp. Do?

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. The company operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets adjuvants, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. In addition, the company offers HB4, a drought tolerant seed technology program. It operates in Argentina, Austria, Bolivia, Brazil, Lebanon, the United States, Italy, Paraguay, the United Kingdom, South Africa, France, Canada, Ukraine, Uruguay, and internationally. The company is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC. Bioceres Crop Solutions Corp. (BIOX) is classified as a micro-cap stock in the Materials sector, specifically within the Chemicals industry. The company is led by CEO Federico Trucco. With a market capitalization of $30M, BIOX is one of the notable companies in the Materials sector.

Bioceres Crop Solutions Corp. (BIOX) Stock Rating — Avoid (April 2026)

As of April 2026, Bioceres Crop Solutions Corp. receives a Avoid rating with a composite score of 29.3/100 and 1 out of 5 stars from the Blank Capital Research quantitative model.BIOX ranks #4,022 out of 4,446 stocks in our coverage universe. Within the Materials sector, Bioceres Crop Solutions Corp. ranks #277 of 284 stocks, placing it in the lower half of its Materials peers. The rating is generated by a multi-factor model that weighs quality (30%), momentum (25%), value (15%), investment (10%), stability (10%), and short interest (10%).

BIOX Stock Price and 52-Week Range

Bioceres Crop Solutions Corp. (BIOX) currently trades at $0.52. The 52-week high for BIOX is $5.18, which means the stock is currently trading -89.9% from its annual peak. The 52-week low is $0.37, putting the stock 41.9% above its annual trough. Recent trading volume was 0 shares, suggesting relatively thin trading activity.

Is BIOX Overvalued or Undervalued? — Valuation Analysis

Bioceres Crop Solutions Corp. (BIOX) carries a value factor score of 35/100 in the Blank Capital model, signaling premium valuation that prices in significant future growth. The price-to-book ratio stands at 0.12x, versus the sector average of 2.83x. The price-to-sales ratio is 0.02x, compared to 0.74x for the average Materials stock.

At current multiples, Bioceres Crop Solutions Corp. trades at a premium to most Materials peers. This elevated valuation may be justified if the company can sustain above-average growth rates and profitability, but it also creates downside risk if earnings disappoint expectations.

Bioceres Crop Solutions Corp. Profitability — ROE, Margins, and Quality Score

Bioceres Crop Solutions Corp. (BIOX) earns a quality factor score of 34/100, signaling below-average profitability metrics relative to the broader market. The return on equity (ROE) is -88.7%, compared to the Materials sector average of 3.3%, which is below typical expectations for high-quality companies. Return on assets (ROA) comes in at -30.8% versus the sector average of 0.6%.

On a margin basis, Bioceres Crop Solutions Corp. reports gross margins of 30.0%, compared to 29.8% for the sector. The operating margin is -9.6% (sector: 6.0%). Net profit margin stands at -17.7%, versus 3.0% for the average Materials stock. Profitability is below benchmark levels, which may reflect industry headwinds, elevated reinvestment, or structural challenges.

BIOX Debt, Balance Sheet, and Financial Health

Bioceres Crop Solutions Corp. has a debt-to-equity ratio of 104.0%, compared to the Materials sector average of 41.0%. Leverage is within a manageable range for the industry, though investors should monitor debt trends over time. Total debt on the balance sheet is $277M. Cash and equivalents stand at $33M.

BIOX has a beta of 1.30, meaning it is more volatile than the broader market — a $10,000 investment in BIOX would be expected to move 29.7% more than the S&P 500 on any given day. The stability factor score for Bioceres Crop Solutions Corp. is 20/100, suggesting elevated price swings that may be unsuitable for conservative portfolios.

Bioceres Crop Solutions Corp. Revenue and Earnings History — Quarterly Trend

In TTM 2026, Bioceres Crop Solutions Corp. reported revenue of $332M. Net income for the quarter was $-59M. Gross margin was 30.0%. Operating income came in at $-32M.

In FY 2025, Bioceres Crop Solutions Corp. reported revenue of $332M. Net income for the quarter was $-59M. Gross margin was 30.0%. Revenue grew -28.3% year-over-year compared to FY 2024. Operating income came in at $-32M.

In FY 2024, Bioceres Crop Solutions Corp. reported revenue of $462M. Net income for the quarter was $7M. Gross margin was 34.0%. Revenue grew 11.4% year-over-year compared to FY 2023. Operating income came in at $15M.

In FY 2023, Bioceres Crop Solutions Corp. reported revenue of $415M. Net income for the quarter was $20M. Gross margin was 37.5%. Revenue grew 26.4% year-over-year compared to FY 2022. Operating income came in at $29M.

Over the past 8 quarters, Bioceres Crop Solutions Corp. has demonstrated a growth trajectory, with revenue expanding from $161M to $332M. Investors analyzing BIOX stock should weigh these quarterly trends alongside the valuation and quality metrics discussed above.

BIOX Dividend Yield and Income Analysis

Bioceres Crop Solutions Corp. (BIOX) does not currently pay a dividend. This is common among smaller companies in the Chemicals industry that prefer to reinvest cash flows into business expansion rather than returning capital to shareholders. Income-focused investors looking for Materials dividend stocks may want to explore other Materials stocks or use the stock screener to filter by dividend yield.

BIOX Momentum and Technical Analysis Profile

Bioceres Crop Solutions Corp. (BIOX) has a momentum factor score of 6/100, signaling weak relative price performance. Stocks with low momentum scores have historically tended to continue underperforming in the near term. The investment factor score is 53/100, which measures capital allocation efficiency and asset growth patterns. The short interest score of 51/100 reflects moderate short selling activity.

BIOX vs Competitors — Materials Sector Ranking and Peer Comparison

Within the Materials sector, Bioceres Crop Solutions Corp. (BIOX) ranks #277 out of 284 stocks based on the Blank Capital composite score. This places BIOX in the lower half of all Materials stocks in our coverage universe. Key competitors and sector peers include CF Industries Holdings, Inc. (CF) with a score of 56.6/100, Nutrien Ltd. (NTR) with a score of 56.6/100, CVR PARTNERS, LP (UAN) with a score of 55.6/100, LSB INDUSTRIES, INC. (LXU) with a score of 53.6/100, and ACME UNITED CORP (ACU) with a score of 51.2/100.

Comparing BIOX against the S&P 500 benchmark is also instructive for understanding relative performance. Investors can view the full BIOX vs S&P 500 (SPY) comparison to assess how Bioceres Crop Solutions Corp. stacks up against the broader market across all factor dimensions.

BIOX Next Earnings Date

No upcoming earnings date has been announced for Bioceres Crop Solutions Corp. (BIOX) at this time. Check the earnings calendar for the latest scheduling updates across all stocks in our coverage universe.

Should You Buy BIOX? — Investment Thesis Summary

The quantitative profile for Bioceres Crop Solutions Corp. suggests caution. The quality score of 34/100 flags below-average profitability. The value score of 35/100 indicates premium valuation. Momentum is weak at 6/100, a headwind for near-term performance. High volatility (stability score 20/100) increases portfolio risk.

In summary, Bioceres Crop Solutions Corp. (BIOX) earns a Avoid rating with a composite score of 29.3/100 as of April 2026. The rating is derived from the Blank Capital Research methodology, which combines six factor dimensions into a single quantitative ranking. Investors should consider these quantitative signals alongside their own fundamental research, risk tolerance, and investment time horizon before making buy or sell decisions on BIOX stock.

Related Resources for BIOX Investors

Explore more research and tools: BIOX vs S&P 500 comparison, top Materials stocks, stock screener, our methodology, quality factor explained, value factor explained, momentum factor explained. Compare BIOX head-to-head with peers: BIOX vs CF, BIOX vs NTR, BIOX vs UAN.

Business quality

Valuation edge

Market alpha

Unlock Investment Thesis

Unlock Performance & Technicals

Unlock Valuation Tools

Institutional peer matrix

Dispersion: efficiency vs. valuation

Lateral intelligence network

Unlock Financial Statements

Unlock Ownership & Management

Intelligence Feed

What Recent Funding Pressures Mean For Bioceres Crop Solutions Valuation Narrative

A Message from Our Chief Executive Officer

L'Europe finit sans direction, meilleur mois pour le CAC depuis plus d'un an

Wall Street vue dans le rouge, l'Europe prudente au terme d'un mois agit

L'Europe ouvre en ordre dispers avec les donnes conomiques et les rsultats financiers

Unlock Earnings Transcripts

Institutional Intelligence FAQ

Related Research & Tools

Related Materials Stocks